Lawsuit against Biontech over Corona vaccine

Curevac accuses Biontech of patent infringement

Glaxo-Smithkline buys Affinivax for up to $3.3 billion

Hedge funds attack German companies

Biotech company slips deep into the red

New drugs against Covid give hope

How companies cheat on climate promises